🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

RecruitingNAAges 18 Years - anyAllAssaf-Harofeh Medical Center
NCT06724861 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * CIPN by self-report (present or absent) \> 3 months after last chemotherapy treatment * age \> 18. Exclusion Criteria: * Pre-chemotherapy neuropathy/ sensory impairment * recurrent falls prior to chemotherapy (more than 2 per year) * CNS involvement * not ambulatory before chemotherapy * Hebrew proficiency not meeting questionnaires' needs.
💊

What it tests

  • Explicit Sensory Retraining for the lower extremities
  • no treatment
📍

Where

1 site
Shamir Medical center
Tzrifin, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy